Advertisement

Neurokutane Syndrome bei Kindern und Jugendlichen

  • Gerhard Kurlemann
Living reference work entry

Latest version View entry history

Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Die neurokutanen Syndrome sind eine heterogene Gruppe von Erkrankungen, die sich durch das gemeinsame Auftreten zerebraler und kutaner Symptome auszeichnen. Beteiligt sein können alle 3 Keimblätter, bevorzugt aber das Ekto- (Haut und Hautanhangsgebilde, ZNS) und Mesoderm (Bindegewebe). Die kutanen Merkmale sind häufig bereits bei der Geburt vorhanden und ermöglichen so eine frühzeitige Diagnose.

Weiterführende Literatur

  1. Aradhya S, Woffendin H, Jakins T et al (2001) A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene account for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 10:2171–2179PubMedCrossRefPubMedCentralGoogle Scholar
  2. Arun D, Gutman DH (2004) Recent advances in neurofibromatosis type 1. Curr Opin Neurol 17:101–105PubMedCrossRefPubMedCentralGoogle Scholar
  3. Barak Y, Nir E (1987) Chediak-Higashi syndrome. Am J Pediatr Hematol Oncol 9:42–55PubMedCrossRefPubMedCentralGoogle Scholar
  4. Barkovich AJ, Frieden IJ, Williams ML (1994) Magnetic resonance of neurocutaneous melanosis. Am J Neuroradiol 5:859–866Google Scholar
  5. Belohradsky BH, Laminger B (1992) Das Chediak-Higashi syndrome. Ergeb Inn Med Kinderheilkd 60:151–240PubMedPubMedCentralGoogle Scholar
  6. Benedikt RA, Brown DC, Walker R, Ghaed VN, Mitchell M, Geyer CA (1993) Sturge-Weber syndrome: cranial MR imaging with Gd-DTPA. Am J Neuroradiol 14:409–415PubMedPubMedCentralGoogle Scholar
  7. Berlin AL, Pallar AS, Chan LS (2002) Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol 47:169–187PubMedCrossRefPubMedCentralGoogle Scholar
  8. Braffman BH, Bilaniuk LT, Zimmerman RA (1988) The central nervous system manifestation of the phakomatoses on MR. Imaging in neuroradiology. Radiol Clin N Am 26:773–800PubMedPubMedCentralGoogle Scholar
  9. Comi AM (2003) Pathophysiology of Sturge-Weber syndrome. J Child Neurol 18:63–67Google Scholar
  10. Cory RC, Clayman DA, Failace WJ, McKee SW, Gama CH (1997) Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome). Am J Neuroradiol 18:751–757PubMedPubMedCentralGoogle Scholar
  11. Costello LC, Hartman TE, Ryu JH (2000) High frequency of pulmonary lymphangioleiomyomatosis in woman with tuberous sclerosis complex. Mayo Clin Proc 75:591–594PubMedCrossRefPubMedCentralGoogle Scholar
  12. Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345–1356PubMedCrossRefPubMedCentralGoogle Scholar
  13. Edelstein S, Naidich TP, Newton TH (2004) The rare phakomatoses. Neuroimaging Clin N Am 14:185–217PubMedCrossRefPubMedCentralGoogle Scholar
  14. Ess KC (2006) The neurobiology of tuberous sclerosis complex. Semin Pediatr Neurol 13:37–42PubMedCrossRefPubMedCentralGoogle Scholar
  15. Forster RD, Williams ML, Barkovich AJ, Hoffman WY, Mathes SJ, Frieden IJ (2001) Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 107:933–941CrossRefGoogle Scholar
  16. Franz DN (2004) Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol 19:690–698PubMedCrossRefPubMedCentralGoogle Scholar
  17. Garcia-Penas JJ, Sanchez M (1994) Incontinentia pigmenti: MR demonstration of brain changes. Am J Neuroradiol 15:1521–1527PubMedPubMedCentralGoogle Scholar
  18. Gareth D, Evans R (2004) Neurofibromatosis type 2. In: Roach ES, van Miller S (Hrsg) Neurocutaneous disorders. Cambridge University Press, CambridgeGoogle Scholar
  19. Guo H, Tong J, Hannan F et al (2005) A neurofibromatosis −1-regulated pathway is required for learning in Drosophila. Nature 403:895–898CrossRefGoogle Scholar
  20. Happle R (1985) Lyonization and the lines of Blaschko. Hum Genet 75:200–206Google Scholar
  21. Hyman SL, Gill D, Shores EA, Steinberg A, Joy P, Gibikote SV, North KN (2003) Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 60:1139–1145PubMedCrossRefPubMedCentralGoogle Scholar
  22. Jentarra G, Snyder SL, Narayanan V (2006) Genetic aspects of neurocutaneous disorders. Semin Pediatr Neurol 13:43–47PubMedCrossRefPubMedCentralGoogle Scholar
  23. Juhasz C, Chugani DC, Muzik O et al (2003) Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60:960–968PubMedCrossRefPubMedCentralGoogle Scholar
  24. Korf BR, Rubenstein AE (2005) Neurofibromatosis, 2. Aufl. Thieme, New YorkGoogle Scholar
  25. Krueger DA, Care MM, Holland K et al (2010) Everolimus for subependymal giant-cell astrozytomas in tuberous sclerosis. N Engl J Med 363:1801–1811PubMedCrossRefPubMedCentralGoogle Scholar
  26. Lance EI, Sreenivan AK, Zabel TA, Kossoff EH, Comi AM (2013) Aspirin use in Sturge-Weber-syndrome: side effects and clinical outcomes. J Child Neurol 28:213–218PubMedCrossRefPubMedCentralGoogle Scholar
  27. Lin DD, Baker PB, Hatfield LA, Comi AM (2006) Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging 24:274–281PubMedCrossRefPubMedCentralGoogle Scholar
  28. Lisch K (1937) Über die Beteiligung der Augen, insbesondere das Vorkommen von Iris-Knötchen bei der Neurofibromatose (Recklinghausen). Z Augenheil 93:137–143Google Scholar
  29. Listernick R, Guttmann DH (1999) Optic pathway gliomas. In: Friedman JM et al (Hrsg) Neurofibromatosis: phenotype, natural history and pathogenesis. Johns Hopkins University Press, BaltimoreGoogle Scholar
  30. Loomis CA (1997) Linear hypopigmentation and hyperpigmentation, including mosaicism. Semin Cutan Med Surg 16:44–53PubMedCrossRefPubMedCentralGoogle Scholar
  31. Lubs MLE, Bauer MS, Formas ME, Djokic B (1991) Lisch nodules in neurofibromatosis type I. N Engl J Med 25:1264–1266CrossRefGoogle Scholar
  32. Niederstadt T, Kurlemann G (2007) Neurokutane Erkrankungen. Radiol up2date 3:247–261CrossRefGoogle Scholar
  33. Nir A, Tajik AJ, Freeman WK et al (1995) Tuberous sclerosis and cardiac rhabdomyoma. Am J Cardiol 76:419–421PubMedCrossRefPubMedCentralGoogle Scholar
  34. Pascual-Castroviejo I, Roche MC, Fernandez VM, Perez-Romero M, Escudero RM, Williams DW, Elster AD (1990) Cranial MR imaging in hypomelanosis of Ito. J Comput Assist Tomogr 14:981–983CrossRefGoogle Scholar
  35. Pascual-Castroviejo I, Roche MC, Martinez-Bermelo A (1998) Hypomelanosis of Ito. A study of 76 infantile cases. Brain and Development 20:36–43PubMedCrossRefPubMedCentralGoogle Scholar
  36. Peters R, Jansen G, Engelbrecht V (2000) Neurocutaneous melanosis with hydrozephalus, intraspinal arachnoid collections and syringomyelia: case report and literature review. Pediatr Radiol 30:238–288CrossRefGoogle Scholar
  37. Rosser T, Panigrahy A, McClintock W (2006) The diverse clinical manifestations of tuberous slerosis complex: a review. Semin Pediatr Neurol 13:27–36PubMedCrossRefPubMedCentralGoogle Scholar
  38. Ruggieri M, Pavone L (2000) Hypomelanosis of Ito: clinical syndrome or just phenotype? J Child Neurol 15:635–644PubMedCrossRefPubMedCentralGoogle Scholar
  39. Shirley MD, Tang H, Gallione CJ et al (2013) Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971–1979PubMedPubMedCentralCrossRefGoogle Scholar
  40. Smahi A, Courtois G, Hadj Rabia S et al (2002) The NF-κB signaling pathway in human disease: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11:2371–2375PubMedCrossRefPubMedCentralGoogle Scholar
  41. Tello R, Blickman JG, Buonomo C, Herrin J (1998) Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol 27:131–138PubMedCrossRefPubMedCentralGoogle Scholar
  42. Thomas-Sohl KA, Vaslow DF, Maria BL (2004) Sturge-Weber syndrome: a review. Pediatr Neurol 30:303–310PubMedCrossRefPubMedCentralGoogle Scholar
  43. Tong J, Hannant F, Zhu Y, Bernards A, Zhong Y (2002) Neurofibromin regulates G protein – stimulated adenylyl cyclase activity. Nat Neurosci 5:95–96PubMedCrossRefPubMedCentralGoogle Scholar
  44. Vehring KH, Kurlemann G, Traupe H, Bonsmann G, Gerding H, Möllmann S, Hamm H (1993) Incontinentia pigmenti bei einem männlichen Säugling. Hautarzt 44:726–730PubMedPubMedCentralGoogle Scholar
  45. Witkop CJ, Quevedo WC, Fitzpatrick TB, King RA (1993) Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (Hrsg) The metabolic basis of inherited disease, 7. Aufl. McGraw Hill, New York, S 2905–2949Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Gerhard Kurlemann
    • 1
  1. 1.Bonifatius Hospital Lingen, Kinderklinik, NeuropädiatrieLingenDeutschland

Section editors and affiliations

  • Georg F. Hoffmann
    • 1
  1. 1.Zentrum für Kinder- und JugendmedizinUniversitätsklinikum HeidelbergHeidelbergDeutschland

Personalised recommendations